Company strategy

With our long-term strategy, we are continuing our evolution as a science-based company operating in the fields of health, nutrition and bioscience. Our strong capacity for growth is anchored in developing customer-centric, innovative solutions addressing key societal and environmental needs. At the same time, we are performance-driven as we focus on increasing our operational excellence, managing costs, and accelerating profitable growth and cash generation.

Food & Beverage

In Food & Beverage, we combine food, beverage and pet food activities in a business group that is uniquely able to meet the needs of customers and consumers by developing sustainable taste, texture, and health solutions. The business group’s portfolio includes breakthrough innovations such as EVERSWEET?, a natural calorie-free sweetener, and CanolaPRO?, a plant-based alternative protein.

Health, Nutrition & Care?

Our Health, Nutrition & Care business group aims to keep the world’s growing population healthy through good nutrition and care. Health, Nutrition & Care provides unique science-based solutions for consumers at every life stage with a rich innovation portfolio that includes ampli-D?, a rapid-acting potent form of vitamin D, an extensive algal lipids portfolio, human milk oligosaccharides-prebiotics, and personalized nutrition initiatives such as Hologram Sciences?.?

Animal Nutrition & Health

Animal Nutrition & Health focuses on specialty solutions for a radical transformation in the sustainability of animal protein production and incorporates essential products such as vitamins, carotenoids, eubiotics and mycotoxin risk management as well as a wide range of impactful innovations such as methane inhibitor Bovaer?. This business group also includes precision initiatives with data-driven decision-making tools for famers like Sustell?, and for veterinarians and animal health practitioners like Verax?.

Our evolution continues

In 2023, DSM became a part of DSM-Firmenich to establish the leading creation and innovation partner in nutrition, beauty and well-being. In preparation for this, we have completed the sale of our Materials businesses in transactions that amount to in excess of €5 billion in aggregate. We continue our approach of actively managing our businesses for growth supported by complementary acquisitions, including of the Erber Group (animal nutrition) and Royal CSK (dairy cultures) in recent years, that strengthen and develop our critical capabilities.??